IP Library Granted Patent US 9,354,242
Granted Patent B2
US 9,354,242 · App. 13/653,069 · Granted May 31, 2016

Glass bead flow rates to facilitate immunodiagnostic test element manufacture

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,354,242
App. No.
13/653,069
Granted
May 31, 2016
Kind
B2
Abstract

A method of preparing a glass bead mixture using inert nanoparticles to improve flow rates of the glass beads for purposes of manufacturing an immunodiagnostic test element, such as a column agglutination test cassette, and a test element made in accordance with the method.

Claims (11)

1. An immunodiagnostic test element comprising:

a planar substrate;

a plurality of test columns supported by said planar substrate, said plurality of test columns being disposed in a linear array in which each of said test columns contain a plurality of micro-sized glass beads and a preselected quantity of inert nanoparticles, the inert nanoparticles comprising fumed silica, wherein the fumed silica nanoparticles are adhered to an exterior surface of the micro-sized glass beads in order to disrupt attractive forces between the micro-sized glass beads and improve flow properties of the micro-sized glass beads.

2. The test element of claim 1 , wherein each of said plurality of test columns further contain at least one aqueous reagent in which the aqueous reagent destroys the bonding of the inert fumed silica nanoparticles to the micro-sized glass beads.

3. The test element of claim 2 , wherein each of said plurality of test columns are made of a substantially clear and substantially rigid material.

4. The test element of claim 3 , wherein the micro-sized glass beads comprise borosilicate having a size between about 50-120 μm in diameter.

5. The test element of claim 3 , wherein the micro-sized glass beads comprise borosilicate having a size of between about 75-90 μm in diameter.

6. The test element of claim 3 , wherein the micro-sized glass beads comprise borosilicate having a size of between about 65-90 μm in diameter.

7. The test element of claim 1 , wherein the preselected quantity of inert nanoparticles comprises about 0.0001% to about 1.0% of the weight of the micro-sized glass beads.

8. The test element of claim 1 , wherein the preselected quantity of inert nanoparticles comprises about 0.0005% to about 0.1% of the weight of the micro-sized glass beads.

9. The test element of claim 8 , wherein the preselected quantity of inert nanoparticles comprises about 0.0005% to about 0.0015% of the weight of the micro-sized glass beads.

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded May 31, 2022
From: BANK OF AMERICA, N.A.
To: ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC
Reel/Frame 060219/0571 →
SECURITY INTEREST Recorded Jul 3, 2014
From: ORTHO-CLINICAL DIAGNOSTICS, INC; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 033276/0104 →